ENHABIT INC (EHAB) Fundamental Analysis & Valuation
NYSE:EHAB • US29332G1022
Current stock price
13.66 USD
0 (0%)
At close:
13.6217 USD
-0.04 (-0.28%)
After Hours:
This EHAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. EHAB Profitability Analysis
1.1 Basic Checks
- In the past year EHAB was profitable.
- EHAB had a positive operating cash flow in the past year.
- In the past 5 years EHAB reported 4 times negative net income.
- EHAB had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of EHAB (-0.39%) is comparable to the rest of the industry.
- EHAB's Return On Equity of -0.86% is in line compared to the rest of the industry. EHAB outperforms 51.00% of its industry peers.
- With a Return On Invested Capital value of 4.84%, EHAB perfoms like the industry average, outperforming 51.00% of the companies in the same industry.
- EHAB had an Average Return On Invested Capital over the past 3 years of 3.51%. This is significantly below the industry average of 8.85%.
- The 3 year average ROIC (3.51%) for EHAB is below the current ROIC(4.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -0.86% | ||
| ROIC | 4.84% |
ROA(3y)-6.25%
ROA(5y)-2.95%
ROE(3y)-14.24%
ROE(5y)-8.07%
ROIC(3y)3.51%
ROIC(5y)4.64%
1.3 Margins
- Looking at the Operating Margin, with a value of 6.02%, EHAB is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
- EHAB's Operating Margin has declined in the last couple of years.
- EHAB has a better Gross Margin (49.04%) than 75.00% of its industry peers.
- In the last couple of years the Gross Margin of EHAB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.02% | ||
| PM (TTM) | N/A | ||
| GM | 49.04% |
OM growth 3Y-12.91%
OM growth 5Y-8.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-0.45%
2. EHAB Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EHAB is destroying value.
- EHAB has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for EHAB has been increased compared to 5 years ago.
- Compared to 1 year ago, EHAB has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 1.94 indicates that EHAB is not a great score, but indicates only limited risk for bankruptcy at the moment.
- EHAB has a Altman-Z score (1.94) which is comparable to the rest of the industry.
- The Debt to FCF ratio of EHAB is 6.81, which is on the high side as it means it would take EHAB, 6.81 years of fcf income to pay off all of its debts.
- EHAB's Debt to FCF ratio of 6.81 is in line compared to the rest of the industry. EHAB outperforms 49.00% of its industry peers.
- A Debt/Equity ratio of 0.80 indicates that EHAB is somewhat dependend on debt financing.
- The Debt to Equity ratio of EHAB (0.80) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 6.81 | ||
| Altman-Z | 1.94 |
ROIC/WACC0.56
WACC8.65%
2.3 Liquidity
- A Current Ratio of 1.63 indicates that EHAB should not have too much problems paying its short term obligations.
- EHAB has a Current ratio of 1.63. This is in the better half of the industry: EHAB outperforms 66.00% of its industry peers.
- A Quick Ratio of 1.63 indicates that EHAB should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.63, EHAB is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.63 | ||
| Quick Ratio | 1.63 |
3. EHAB Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 157.14% over the past year.
- Looking at the last year, EHAB shows a small growth in Revenue. The Revenue has grown by 2.44% in the last year.
- The Revenue has been decreasing by -0.34% on average over the past years.
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)2.44%
Revenue growth 3Y-0.35%
Revenue growth 5Y-0.34%
Sales Q2Q%4.73%
3.2 Future
- Based on estimates for the next years, EHAB will show a very negative growth in Earnings Per Share. The EPS will decrease by -13.24% on average per year.
- EHAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.95% yearly.
EPS Next Y14.28%
EPS Next 2Y9.78%
EPS Next 3Y-7.43%
EPS Next 5Y-13.24%
Revenue Next Year4.35%
Revenue Next 2Y4.61%
Revenue Next 3Y5.38%
Revenue Next 5Y5.95%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. EHAB Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 25.30 indicates a quite expensive valuation of EHAB.
- 61.00% of the companies in the same industry are more expensive than EHAB, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 24.88. EHAB is around the same levels.
- The Price/Forward Earnings ratio is 22.14, which indicates a rather expensive current valuation of EHAB.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of EHAB is on the same level as its industry peers.
- EHAB is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.3 | ||
| Fwd PE | 22.14 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EHAB is on the same level as its industry peers.
- Based on the Price/Free Cash Flow ratio, EHAB is valued cheaply inside the industry as 81.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.53 | ||
| EV/EBITDA | 12.72 |
4.3 Compensation for Growth
- EHAB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- A cheap valuation may be justified as EHAB's earnings are expected to decrease with -7.43% in the coming years.
PEG (NY)1.77
PEG (5Y)N/A
EPS Next 2Y9.78%
EPS Next 3Y-7.43%
5. EHAB Dividend Analysis
5.1 Amount
- No dividends for EHAB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EHAB Fundamentals: All Metrics, Ratios and Statistics
13.66
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-04 2026-03-04/amc
Earnings (Next)05-05 2026-05-05/amc
Inst Owners100.15%
Inst Owner ChangeN/A
Ins Owners2.36%
Ins Owner Change8.05%
Market Cap692.84M
Revenue(TTM)1.06B
Net Income(TTM)-4.60M
Analysts73.33
Price Target12.21 (-10.61%)
Short Float %2.53%
Short Ratio0.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.89%
Min EPS beat(2)-3.12%
Max EPS beat(2)38.89%
EPS beat(4)3
Avg EPS beat(4)28.08%
Min EPS beat(4)-3.12%
Max EPS beat(4)53.19%
EPS beat(8)5
Avg EPS beat(8)19.11%
EPS beat(12)6
Avg EPS beat(12)9.32%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-2.02%
Revenue beat(4)0
Avg Revenue beat(4)-2.62%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)-0.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.27%
Revenue beat(12)0
Avg Revenue beat(12)-3.56%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.84%
PT rev (3m)25.97%
EPS NQ rev (1m)30.61%
EPS NQ rev (3m)26.31%
EPS NY rev (1m)0%
EPS NY rev (3m)8.42%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.3 | ||
| Fwd PE | 22.14 | ||
| P/S | 0.65 | ||
| P/FCF | 10.53 | ||
| P/OCF | 9.8 | ||
| P/B | 1.3 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.72 |
EPS(TTM)0.54
EY3.95%
EPS(NY)0.62
Fwd EY4.52%
FCF(TTM)1.3
FCFY9.5%
OCF(TTM)1.39
OCFY10.2%
SpS20.9
BVpS10.53
TBVpS-7.09
PEG (NY)1.77
PEG (5Y)N/A
Graham Number11.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -0.86% | ||
| ROCE | 6.13% | ||
| ROIC | 4.84% | ||
| ROICexc | 5.05% | ||
| ROICexgc | 48.74% | ||
| OM | 6.02% | ||
| PM (TTM) | N/A | ||
| GM | 49.04% | ||
| FCFM | 6.21% |
ROA(3y)-6.25%
ROA(5y)-2.95%
ROE(3y)-14.24%
ROE(5y)-8.07%
ROIC(3y)3.51%
ROIC(5y)4.64%
ROICexc(3y)3.62%
ROICexc(5y)4.73%
ROICexgc(3y)35.01%
ROICexgc(5y)50.85%
ROCE(3y)4.44%
ROCE(5y)5.87%
ROICexgc growth 3Y-7.89%
ROICexgc growth 5Y-10.93%
ROICexc growth 3Y-3.5%
ROICexc growth 5Y-1.99%
OM growth 3Y-12.91%
OM growth 5Y-8.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-0.45%
F-Score7
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 6.81 | ||
| Debt/EBITDA | 4.94 | ||
| Cap/Depr | 21.78% | ||
| Cap/Sales | 0.46% | ||
| Interest Coverage | 1.97 | ||
| Cash Conversion | 81.92% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.63 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 1.94 |
F-Score7
WACC8.65%
ROIC/WACC0.56
Cap/Depr(3y)15.06%
Cap/Depr(5y)38.37%
Cap/Sales(3y)0.39%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y14.28%
EPS Next 2Y9.78%
EPS Next 3Y-7.43%
EPS Next 5Y-13.24%
Revenue 1Y (TTM)2.44%
Revenue growth 3Y-0.35%
Revenue growth 5Y-0.34%
Sales Q2Q%4.73%
Revenue Next Year4.35%
Revenue Next 2Y4.61%
Revenue Next 3Y5.38%
Revenue Next 5Y5.95%
EBIT growth 1Y36.03%
EBIT growth 3Y-13.21%
EBIT growth 5Y-9.08%
EBIT Next Year36.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.82%
FCF growth 3Y21.48%
FCF growth 5Y25.31%
OCF growth 1Y38.09%
OCF growth 3Y-4.08%
OCF growth 5Y23.21%
ENHABIT INC / EHAB Fundamental Analysis FAQ
What is the fundamental rating for EHAB stock?
ChartMill assigns a fundamental rating of 4 / 10 to EHAB.
What is the valuation status for EHAB stock?
ChartMill assigns a valuation rating of 4 / 10 to ENHABIT INC (EHAB). This can be considered as Fairly Valued.
Can you provide the profitability details for ENHABIT INC?
ENHABIT INC (EHAB) has a profitability rating of 4 / 10.
What is the expected EPS growth for ENHABIT INC (EHAB) stock?
The Earnings per Share (EPS) of ENHABIT INC (EHAB) is expected to grow by 14.28% in the next year.